aluates Reports

$ 0.0

Automative

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-19Z5855

Global Prostate Cancer Molecular Diagnostics Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Code: QYRE-Auto-19Z5855

Report

February 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Qiagen NV

Foundationmedicine

Genetech

Gpmedical

Premed

Berryoncology

Gene+

Annoroad

Topgen

Geneis

Prostate Cancer Molecular Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prostate Cancer Molecular Diagnostics Market

A molecular approach for diagnosing prostate cancer

The global Prostate Cancer Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Molecular Diagnostics.

Report Scope

The Prostate Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate Cancer Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Prostate Cancer Molecular Diagnostics Market
CAGR	5%
Segment by Type	PCR FISH DNA Sequencing Gene Chip
Segment by Application	Clinical Diagnosis Drug Screening Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Qiagen, Foundationmedicine, Genetech, Gpmedical, Premed, Berryoncology, Gene+, Annoroad, Topgen, Geneis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prostate Cancer Molecular Diagnostics Market report?

Ans: The main players in the Prostate Cancer Molecular Diagnostics Market are Qiagen, Foundationmedicine, Genetech, Gpmedical, Premed, Berryoncology, Gene+, Annoroad, Topgen, Geneis

What are the Application segmentation covered in the Prostate Cancer Molecular Diagnostics Market report?

Ans: The Applications covered in the Prostate Cancer Molecular Diagnostics Market report are Clinical Diagnosis, Drug Screening, Research

What are the Type segmentation covered in the Prostate Cancer Molecular Diagnostics Market report?

Ans: The Types covered in the Prostate Cancer Molecular Diagnostics Market report are PCR, FISH, DNA Sequencing, Gene Chip

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 PCR

1.2.3 FISH

1.2.4 DNA Sequencing

1.2.5 Gene Chip

1.3 Market by Application

1.3.1 Global Prostate Cancer Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Diagnosis

1.3.3 Drug Screening

1.3.4 Research

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Molecular Diagnostics Market Perspective (2019-2030)

2.2 Prostate Cancer Molecular Diagnostics Growth Trends by Region

2.2.1 Global Prostate Cancer Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate Cancer Molecular Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Prostate Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Prostate Cancer Molecular Diagnostics Market Dynamics

2.3.1 Prostate Cancer Molecular Diagnostics Industry Trends

2.3.2 Prostate Cancer Molecular Diagnostics Market Drivers

2.3.3 Prostate Cancer Molecular Diagnostics Market Challenges

2.3.4 Prostate Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Molecular Diagnostics Players by Revenue

3.1.1 Global Top Prostate Cancer Molecular Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Prostate Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Prostate Cancer Molecular Diagnostics Revenue

3.4 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Molecular Diagnostics Revenue in 2023

3.5 Prostate Cancer Molecular Diagnostics Key Players Head office and Area Served

3.6 Key Players Prostate Cancer Molecular Diagnostics Product Solution and Service

3.7 Date of Enter into Prostate Cancer Molecular Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Molecular Diagnostics Breakdown Data by Type

4.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030)

5 Prostate Cancer Molecular Diagnostics Breakdown Data by Application

5.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate Cancer Molecular Diagnostics Market Size (2019-2030)

6.2 North America Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Prostate Cancer Molecular Diagnostics Market Size by Country (2019-2024)

6.4 North America Prostate Cancer Molecular Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Molecular Diagnostics Market Size (2019-2030)

7.2 Europe Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2019-2024)

7.4 Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Molecular Diagnostics Market Size (2019-2030)

9.2 Latin America Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Qiagen

11.1.1 Qiagen Company Detail

11.1.2 Qiagen Business Overview

11.1.3 Qiagen Prostate Cancer Molecular Diagnostics Introduction

11.1.4 Qiagen Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.1.5 Qiagen Recent Development

11.2 Foundationmedicine

11.2.1 Foundationmedicine Company Detail

11.2.2 Foundationmedicine Business Overview

11.2.3 Foundationmedicine Prostate Cancer Molecular Diagnostics Introduction

11.2.4 Foundationmedicine Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.2.5 Foundationmedicine Recent Development

11.3 Genetech

11.3.1 Genetech Company Detail

11.3.2 Genetech Business Overview

11.3.3 Genetech Prostate Cancer Molecular Diagnostics Introduction

11.3.4 Genetech Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.3.5 Genetech Recent Development

11.4 Gpmedical

11.4.1 Gpmedical Company Detail

11.4.2 Gpmedical Business Overview

11.4.3 Gpmedical Prostate Cancer Molecular Diagnostics Introduction

11.4.4 Gpmedical Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.4.5 Gpmedical Recent Development

11.5 Premed

11.5.1 Premed Company Detail

11.5.2 Premed Business Overview

11.5.3 Premed Prostate Cancer Molecular Diagnostics Introduction

11.5.4 Premed Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.5.5 Premed Recent Development

11.6 Berryoncology

11.6.1 Berryoncology Company Detail

11.6.2 Berryoncology Business Overview

11.6.3 Berryoncology Prostate Cancer Molecular Diagnostics Introduction

11.6.4 Berryoncology Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.6.5 Berryoncology Recent Development

11.7 Gene+

11.7.1 Gene+ Company Detail

11.7.2 Gene+ Business Overview

11.7.3 Gene+ Prostate Cancer Molecular Diagnostics Introduction

11.7.4 Gene+ Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.7.5 Gene+ Recent Development

11.8 Annoroad

11.8.1 Annoroad Company Detail

11.8.2 Annoroad Business Overview

11.8.3 Annoroad Prostate Cancer Molecular Diagnostics Introduction

11.8.4 Annoroad Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.8.5 Annoroad Recent Development

11.9 Topgen

11.9.1 Topgen Company Detail

11.9.2 Topgen Business Overview

11.9.3 Topgen Prostate Cancer Molecular Diagnostics Introduction

11.9.4 Topgen Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.9.5 Topgen Recent Development

11.10 Geneis

11.10.1 Geneis Company Detail

11.10.2 Geneis Business Overview

11.10.3 Geneis Prostate Cancer Molecular Diagnostics Introduction

11.10.4 Geneis Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024)

11.10.5 Geneis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Qiagen NV

Foundationmedicine

Genetech

Gpmedical

Premed

Berryoncology

Gene+

Annoroad

Topgen

Geneis

List of Tables

Table 1. Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of PCR

Table 3. Key Players of FISH

Table 4. Key Players of DNA Sequencing

Table 5. Key Players of Gene Chip

Table 6. Global Prostate Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Prostate Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Prostate Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Prostate Cancer Molecular Diagnostics Market Share by Region (2019-2024)

Table 10. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Prostate Cancer Molecular Diagnostics Market Share by Region (2025-2030)

Table 12. Prostate Cancer Molecular Diagnostics Market Trends

Table 13. Prostate Cancer Molecular Diagnostics Market Drivers

Table 14. Prostate Cancer Molecular Diagnostics Market Challenges

Table 15. Prostate Cancer Molecular Diagnostics Market Restraints

Table 16. Global Prostate Cancer Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Prostate Cancer Molecular Diagnostics Market Share by Players (2019-2024)

Table 18. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2023)

Table 19. Ranking of Global Top Prostate Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Prostate Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Prostate Cancer Molecular Diagnostics Product Solution and Service

Table 23. Date of Enter into Prostate Cancer Molecular Diagnostics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Prostate Cancer Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2019-2024)

Table 27. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2025-2030)

Table 29. Global Prostate Cancer Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2019-2024)

Table 31. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2025-2030)

Table 33. North America Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Prostate Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Prostate Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Prostate Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Prostate Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Qiagen Company Detail

Table 49. Qiagen Business Overview

Table 50. Qiagen Prostate Cancer Molecular Diagnostics Product

Table 51. Qiagen Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 52. Qiagen Recent Development

Table 53. Foundationmedicine Company Detail

Table 54. Foundationmedicine Business Overview

Table 55. Foundationmedicine Prostate Cancer Molecular Diagnostics Product

Table 56. Foundationmedicine Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 57. Foundationmedicine Recent Development

Table 58. Genetech Company Detail

Table 59. Genetech Business Overview

Table 60. Genetech Prostate Cancer Molecular Diagnostics Product

Table 61. Genetech Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 62. Genetech Recent Development

Table 63. Gpmedical Company Detail

Table 64. Gpmedical Business Overview

Table 65. Gpmedical Prostate Cancer Molecular Diagnostics Product

Table 66. Gpmedical Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 67. Gpmedical Recent Development

Table 68. Premed Company Detail

Table 69. Premed Business Overview

Table 70. Premed Prostate Cancer Molecular Diagnostics Product

Table 71. Premed Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 72. Premed Recent Development

Table 73. Berryoncology Company Detail

Table 74. Berryoncology Business Overview

Table 75. Berryoncology Prostate Cancer Molecular Diagnostics Product

Table 76. Berryoncology Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 77. Berryoncology Recent Development

Table 78. Gene+ Company Detail

Table 79. Gene+ Business Overview

Table 80. Gene+ Prostate Cancer Molecular Diagnostics Product

Table 81. Gene+ Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 82. Gene+ Recent Development

Table 83. Annoroad Company Detail

Table 84. Annoroad Business Overview

Table 85. Annoroad Prostate Cancer Molecular Diagnostics Product

Table 86. Annoroad Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 87. Annoroad Recent Development

Table 88. Topgen Company Detail

Table 89. Topgen Business Overview

Table 90. Topgen Prostate Cancer Molecular Diagnostics Product

Table 91. Topgen Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 92. Topgen Recent Development

Table 93. Geneis Company Detail

Table 94. Geneis Business Overview

Table 95. Geneis Prostate Cancer Molecular Diagnostics Product

Table 96. Geneis Revenue in Prostate Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 97. Geneis Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate Cancer Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Prostate Cancer Molecular Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. PCR Features

Figure 4. FISH Features

Figure 5. DNA Sequencing Features

Figure 6. Gene Chip Features

Figure 7. Global Prostate Cancer Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Prostate Cancer Molecular Diagnostics Market Share by Application: 2023 VS 2030

Figure 9. Clinical Diagnosis Case Studies

Figure 10. Drug Screening Case Studies

Figure 11. Research Case Studies

Figure 12. Prostate Cancer Molecular Diagnostics Report Years Considered

Figure 13. Global Prostate Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Prostate Cancer Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Prostate Cancer Molecular Diagnostics Market Share by Region: 2023 VS 2030

Figure 16. Global Prostate Cancer Molecular Diagnostics Market Share by Players in 2023

Figure 17. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Molecular Diagnostics Revenue in 2023

Figure 19. North America Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Prostate Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 21. United States Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Prostate Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 25. Germany Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Prostate Cancer Molecular Diagnostics Market Share by Region (2019-2030)

Figure 33. China Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Prostate Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 41. Mexico Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Prostate Cancer Molecular Diagnostics Market Share by Country (2019-2030)

Figure 45. Turkey Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Prostate Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Qiagen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 48. Foundationmedicine Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 49. Genetech Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 50. Gpmedical Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 51. Premed Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 52. Berryoncology Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 53. Gene+ Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 54. Annoroad Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 55. Topgen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 56. Geneis Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions